Company intelligence / Profile preview

Comeos

Ownership: Private
Development stage: Other

Overview

Comeo is a Belgian market leader in smart medication and oncology treatment management platforms. Its flagship product, ComeoCare, is deployed in over 30 healthcare institutions across Belgium and Switzerland. The platform enables seamless coordination among multiple departments and medical staff for complex medicinal treatments—especially in oncology—improving safety and efficiency through features like closed-loop automation from prescription to IV pump programming. The company has been active for over two decades as a trusted partner to healthcare organizations[1].

Therapeutic areas: OncologyOther
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

B.Braun (integration with Oncosafety for closed-loop solution)

Beyond the preview

Go deeper on Comeos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Comeos.

Explore the full profile